Since the introduction of antibiotics, the bacteria they treat have been adapting and changing to become more resistant. These antibiotic-resistant bacteria are called superbugs, and they cause serious bacterial infections that are extremely difficult to treat.
The World Health Organization has identified three bacteria as top priorities for new therapies, including Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacterales. We provide innovative therapeutic development services for new targets in these three areas and are committed to advancing the development of therapies in the field of superbugs to change and save lives.
Rapid and accurate superbug detection and antibiotic resistance testing is a critical need to address the escalating number of superbug infections. Ace Therapeutics offers solutions for superbug identification and recognition, including a variety of commonly used or innovative testing protocols. We are committed to laying the groundwork for your superbug drug development program.
Scientists have been trying to stay ahead of emerging drug-resistant bacteria by developing new drugs, but it's a daunting task. As an excellent partner for researchers and the pharmaceutical industry, we offer comprehensive drug development solutions against superbugs, including novel antibiotics, antimicrobial peptides, phage therapies, immunotherapies and more.
Join the fight against superbugs! Learn more about our services and contact us to advance drug development.
Contact Us
